An interim analysis of quality of life in patients with relapsing-remitting multiple sclerosis treated with delayed-release dimethyl fumarate

被引：0
|
作者：
Sarda, S. P. [6 ]
Kita, M. [1 ]
Fox, R. J. [2 ]
Gold, R. [3 ]
Giovannoni, G. [4 ]
Phillips, T. [5 ]
Okwuokenye, M. [6 ]
Kong, J. [6 ]
Zhang, R. [6 ]
Kurukulasuriya, N. C. [6 ]
Kappos, L. [7 ]
机构：
[1] Virginia Mason Med Ctr, Seattle, WA 98101 USA
[2] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH USA
[3] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany
[4] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England
[5] Baylor Inst Immunol Res, Multiple Sclerosis Program, Dallas, TX USA
[6] Biogen Idec Inc, Cambridge, MA USA
[7] Univ Basel Hosp, Basel Neurol, CH-4031 Basel, Switzerland
来源：
MULTIPLE SCLEROSIS JOURNAL | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P790
引用
收藏
页码：413 / 414
页数：2
相关论文
共 50 条
  • [31] Effects of Delayed-Release Dimethyl Fumarate (DMF) on Health-Related Quality of Life in Patients With Relapsing-Remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies
    Kita, Mariko
    Fox, Roberti
    Gold, Ralf
    Giovannoni, Gavin
    Phillips, J. Theodore
    Sarda, Sujata P.
    Kong, Jessica
    Viglietta, Vissia
    Sheikh, Sarah I.
    Okwuokenye, Macaulay
    Kappos, Ludwig
    CLINICAL THERAPEUTICS, 2014, 36 (12) : 1958 - 1971
  • [32] The effect of delayed-release dimethyl fumarate on lymphocyte subsets and immunoglobulins in patients with relapsing-remitting multiple sclerosis: Interim results of an open-label phase 3 study
    von Hehn, C.
    Mehta, D.
    Prada, C.
    Yang, L.
    Liu, S.
    Ray, S.
    Sheikh, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 416 - 416
  • [33] A Retrospective Analysis of Real-World Discontinuation Rates with Delayed-Release Dimethyl Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis
    Michelle Allan
    Lindsay Grant
    Neurology and Therapy, 2020, 9 : 85 - 92
  • [34] Interim analysis of quality of life in patients with relapsing remitting multiple sclerosis treated with BG-12 (dimethyl fumarate) in the ENDORSE study
    Kita, M.
    Fox, R. J.
    Gold, R.
    Giovannoni, G.
    Phillips, J. T.
    Sarda, S. P.
    Kong, J.
    Zhang, R.
    Viglietta, V.
    Sheikh, S. I.
    Kappos, L.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 530 - 530
  • [35] Risk factors for lymphopenia in patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarate
    Morales, Fabian Sierra
    Koralnik, Igor J.
    Gautam, Shiva
    Samaan, Soleil
    Sloane, Jacob A.
    JOURNAL OF NEUROLOGY, 2020, 267 (01) : 125 - 131
  • [36] Characterization of lymphopenia in relapsing-remitting multiple sclerosis patients treated with dimethyl fumarate and fingolimod
    Nakhaei-Nejad, M.
    Barilla, D.
    Lee, C-H.
    Blevins, G.
    Giuliani, F.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 618 - 618
  • [37] COST-UTILITY ANALYSIS OF DELAYED-RELEASE DIMETHYL FUMERATE FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS IN PORTUGAL
    Silva Miguel, L.
    de Sa, J.
    Pinheiro, B.
    Acosta, C.
    VALUE IN HEALTH, 2015, 18 (07) : A758 - A758
  • [38] Efficacy and safety of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis patients with cardiovascular disease: integrated analysis of the phase 3 DEFINE and CONFIRM studies
    Havrdova, E.
    Fox, R. J.
    Gold, R.
    Li, J.
    Zhang, A.
    Potts, J.
    Marantz, J. L.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 551 - 552
  • [39] Efficacy and Tolerability of Delayed-release Dimethyl Fumarate in Black, Hispanic, and Asian Patients with Relapsing-Remitting Multiple Sclerosis: Post Hoc Integrated Analysis of DEFINE and CONFIRM
    Fox R.J.
    Gold R.
    Phillips J.T.
    Okwuokenye M.
    Zhang A.
    Marantz J.L.
    Neurology and Therapy, 2017, 6 (2) : 175 - 187
  • [40] Efficacy of delayed-release dimethyl fumarate for relapsing-remitting multiple sclerosis (RRMS) in "non-responders'' to prior treatment with interferon beta
    Fernandez, O.
    Giovannoni, G.
    Fox, R. J.
    Gold, R.
    Phillips, J. T.
    Yang, M.
    Zhang, A.
    Kurukulasuriya, N. C.
    JOURNAL OF NEUROLOGY, 2014, 261 : S19 - S20
12345